Enfusion, Inc.
ENFN
ENFN was delisted on the 17th of April, 2025.
75 hedge funds and large institutions have $746M invested in Enfusion, Inc. in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 39 increasing their positions, 15 reducing their positions, and 18 closing their positions.
9,343% more call options, than puts
Call options by funds: $661K | Put options by funds: $7K
160% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 15
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
10% less funds holding
Funds holding: 83 → 75 (-8)
16% less capital invested
Capital invested by funds: $892M → $746M (-$146M)
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$14M |
| 2 |
BlackRock
New York
|
+$7.05M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.87M |
| 4 |
CC
Clearline Capital
New York
|
+$4.27M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Irenic Capital Management
New York
|
-$9.86M |
| 2 |
Two Sigma Investments
New York
|
-$2.4M |
| 3 |
Two Sigma Advisers
New York
|
-$767K |
| 4 |
Millennium Management
New York
|
-$765K |
| 5 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
-$668K |
ENFN Hedge Fund Activity: Q3 2023 in Review
75 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q3 2023, worth a combined $746M — down 16% from $892M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of ENFN and 10 opened new positions — a net loss of 8 holders — while 15 trimmed existing stakes and 39 added.
The largest buyer was Brown Capital Management, adding an estimated $14M. The largest seller was Irenic Capital Management, cutting an estimated $9.86M.
- 75 institutional investors held Enfusion, Inc. (ENFN) as of Q3 2023, down from 83 in Q2 2023.
- Funds reported $746M of Enfusion, Inc. stock for Q3 2023, down 16% quarter-over-quarter.
- 10 funds opened new Enfusion, Inc. positions in Q3 2023 and 18 closed out, a net change of -8 holders.
- The largest Enfusion, Inc. buyer in Q3 2023 was Brown Capital Management, an estimated $14M added.
- The largest Enfusion, Inc. seller in Q3 2023 was Irenic Capital Management, an estimated $9.86M sold.
Based on aggregated 13F filings for Q3 2023.